Literature DB >> 16304187

Caspofungin and liposomal amphotericin B therapy of experimental murine scedosporiosis.

Rosie Bocanegra1, Laura K Najvar, Steve Hernandez, Dora I McCarthy, John R Graybill.   

Abstract

Immunosuppressed mice were infected intravenously with conidia of Scedosporium prolificans. Treatment was begun 1 day later with liposomal amphotericin B, caspofungin, or both drugs initiated concurrently. Amphotericin B and caspofungin were each effective, but combined therapy did not appear to offer advantages over liposomal amphotericin B alone.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16304187      PMCID： PMC1315953          DOI： 10.1128/AAC.49.12.5139-5141.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  10 in total

1.  Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients.

Authors:  Kieren A Marr; Rachel A Carter; Fulvio Crippa; Anna Wald; Lawrence Corey
Journal:  Clin Infect Dis       Date:  2002-02-26       Impact factor: 9.079

Review 2.  Deep infections caused by Scedosporium prolificans. A report on 16 cases in Spain and a review of the literature. Scedosporium Prolificans Spanish Study Group.

Authors:  J Berenguer; J L Rodríguez-Tudela; C Richard; M Alvarez; M A Sanz; L Gaztelurrutia; J Ayats; J V Martinez-Suarez
Journal:  Medicine (Baltimore)       Date:  1997-07       Impact factor: 1.889

3.  Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome.

Authors:  Shahid Husain; Patricia Muñoz; Graeme Forrest; Barbara D Alexander; Jyoti Somani; Kathleen Brennan; Marilyn M Wagener; Nina Singh
Journal:  Clin Infect Dis       Date:  2004-12-08       Impact factor: 9.079

4.  Voriconazole treatment for less-common, emerging, or refractory fungal infections.

Authors:  John R Perfect; Kieren A Marr; Thomas J Walsh; Richard N Greenberg; Bertrand DuPont; Juliàn de la Torre-Cisneros; Gudrun Just-Nübling; Haran T Schlamm; Irja Lutsar; Ana Espinel-Ingroff; Elizabeth Johnson
Journal:  Clin Infect Dis       Date:  2003-04-22       Impact factor: 9.079

5.  In vitro synergistic interaction between amphotericin B and pentamidine against Scedosporium prolificans.

Authors:  Javier Afeltra; Eric Dannaoui; Jacques F G M Meis; Juan L Rodriguez-Tudela; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

6.  Fatal Scedosporium prolificans (S. inflatum) fungemia following allogeneic bone marrow transplantation: report of a case in the United States.

Authors:  R T Spielberger; B R Tegtmeier; M R O'Donnell; J I Ito
Journal:  Clin Infect Dis       Date:  1995-10       Impact factor: 9.079

7.  Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi.

Authors:  Shahid Husain; Barbara D Alexander; Patricia Munoz; Robin K Avery; Sally Houston; Timothy Pruett; Richard Jacobs; Edward A Dominguez; Jan G Tollemar; Katherine Baumgarten; Chen M Yu; Marilyn M Wagener; Peter Linden; Shimon Kusne; Nina Singh
Journal:  Clin Infect Dis       Date:  2003-07-09       Impact factor: 9.079

8.  Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase.

Authors:  M B Kurtz; I B Heath; J Marrinan; S Dreikorn; J Onishi; C Douglas
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

9.  Nosocomial outbreak caused by Scedosporium prolificans (inflatum): four fatal cases in leukemic patients.

Authors:  M Alvarez; B Lopez Ponga; C Rayon; J Garcia Gala; M C Roson Porto; M Gonzalez; J V Martinez-Suarez; J L Rodriguez-Tudela
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

10.  Non-Candida fungal infections after bone marrow transplantation: risk factors and outcome.

Authors:  V A Morrison; R J Haake; D J Weisdorf
Journal:  Am J Med       Date:  1994-06       Impact factor: 4.965
  10 in total
  4 in total

1.  Macrophage reporter cell assay for screening immunopharmacological activity of cell wall-active antifungals.

Authors:  Russell E Lewis; Guangling Liao; Katherine Young; Cameron Douglas; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2014-01-06       Impact factor: 5.191

Review 2.  Infections caused by Scedosporium spp.

Authors:  Karoll J Cortez; Emmanuel Roilides; Flavio Quiroz-Telles; Joseph Meletiadis; Charalampos Antachopoulos; Tena Knudsen; Wendy Buchanan; Jeffrey Milanovich; Deanna A Sutton; Annette Fothergill; Michael G Rinaldi; Yvonne R Shea; Theoklis Zaoutis; Shyam Kottilil; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

3.  Effects of double and triple combinations of antifungal drugs in a murine model of disseminated infection by Scedosporium prolificans.

Authors:  M Mar Rodríguez; Enrique Calvo; Carolina Serena; Marçal Mariné; F Javier Pastor; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2009-02-17       Impact factor: 5.191

4.  Successful Treatment of Scedosporium Sinusitis in Two Lung Transplant Recipients: Review of the Literature and Recommendations for Management.

Authors:  Elisabeth H Ference; Bernard M Kubak; Paul Zhang; Jeffrey D Suh
Journal:  Allergy Rhinol (Providence)       Date:  2019-02-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.